Abstract
Maple Syrup Urine Disease (MSUD) is an inborn error of metabolism caused by a deficiency of branched α-ketoacid dehydrogenase complex (BCKDC) activity. Branched-chain amino acids (BCAA) accumulation is, at least in part, responsible for neurological disturbances characteristic of this metabolic disorder. Experimental studies demonstrated that high levels of BCAA induce brain oxidative stress. Considering that many antioxidants are obtained from the diet, the dietary restriction in MSUD patients probably produce deficiency of vitamins and micronutrients involved in antioxidant defenses. Supplementation with synthetic melatonin has been used to prevention and treatment of pathological conditions, including brain diseases. In this study, we aimed at investigating the potential neuroprotective effect of melatonin treatment in a MSUD experimental model. Infant rats (7 day old) received twice daily subcutaneous injections of a BCAA pool (0.21472 g/kg, 190 mmol/L leucine, 59 mmol/L isoleucine and 69 mmol/L valine in saline solution (15.8 µL/g per weight/injection) or saline alone, and supplemented with melatonin (10 mg/kg, intraperitoneal) for 21 days. Oxidative stress parameters, i.e. antioxidant enzyme activity, reactive species production and damage to lipids and proteins, were assessed in the cerebral cortex, hippocampus and striatum at twenty-eight days of age. In addition, the damage to blood cell DNA was evaluated. The chronic administration of BCAA pool in infant rats induced significant oxidative stress (p < 0.05) - such as oxidation of lipids and proteins, imbalance in antioxidant enzymes activities - damages in DNA (p < 0.05) and in brain structures (cerebral cortex, hippocampus and striatum). Notably, melatonin supplementation was able to ameliorate the oxidative (p < 0.05) and antioxidant (p < 0.05) parameters in the brain and blood of the rat model of MSUD. Our results show that melatonin could be a promising therapeutic agent for MSUD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126. https://doi.org/10.1016/S0076-6879(84)05016-3
Ahmad A, Khan MM, Ishrat T, Khan MB, Khuwaja G, Raza SS, Shrivastava P, Islam F (2011) Synergistic effect of selenium and melatonin on neuroprotection in cerebral ischemia in rats. Biol Trace Elem Res 139:81–96. https://doi.org/10.1007/s12011-010-8643-z
Aksenova MY, Markesbery WR (2001) Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer’s disease. Neurosci Lett 302:141–145. https://doi.org/10.1016/S0304-3940(01)01636-6
Alghamdi BS (2018) The neuroprotective role of melatonin in neurological disorders. J Neurosci Res 96:1136–1149. https://doi.org/10.1002/jnr.24220
Artuch R, Colome C, Sierra C, Brandi N, Lambruschini N, Campistol J, Ugarte D, Vilaseca MA (2004) A longitudinal study of antioxidante status in phenylketonuric patients. Clin Biochem 37:198–203. https://doi.org/10.1016/j.clinbiochem.2003.10.017
Bannister JV, Calabrese L (1987) Assays for SOD. Methods Biochem Anal 32:279–312
Barschak AG, Sitta A, Deon M, de Oliveira MH, Haeser A, Dutra-Filho CS, Wajner M, Vargas CR (2006) Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease. Metab Brain Dis 21: 279–286. https://doi.org/10.1007/s11011-006-9030-5
Barschak AG, Sitta A, Deon M, Barden AT, Dutra-Filho CS, Wajner M, Vargas CR (2008a) Oxidative stress in plasma from maple syrup urine disease patients during treatment. Metab Brain Dis 23:71–80. https://doi.org/10.1007/s11011-007-9077-y
Barschak AG, Marchesan C, Sitta A, Deon M, Giugliani R, Wajner M, Vargas CR (2008b) Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Clin Biochem 41:317–324. https://doi.org/10.1016/j.clinbiochem.2007.11.015
Barschak AG, Sitta A, Deon M, Busanello EN, Coelho DM, Cipriani F, Dutra-Filho CS, Giugliani R, Wajner M, Vargas CR (2009) Amino acids levels and lipid peroxidation in maple syrup urine disease patients. Clin Biochem 42:462–466. https://doi.org/10.1016/j.clinbiochem.2008.12.005
Bridi R, Araldi J, Sgarbi MB, Testa CG, Durigon K, Wajner M, Dutra-Filho CS (2003) Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Dev Neurosci 21:327–332. https://doi.org/10.1016/S0736-5748(03)00074-1
Bridi R, Braun CA, Zorzi GK, Wannmacher CMD, Wajner M, Lissi EG, Dutra-Filho CS (2005) Alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidante defences in cerebral cortex from young rats. Metab Brain Dis 20:155–167. https://doi.org/10.1007/s11011-005-4152-8
Bridi R, Fontella FU, Pulrolnik V, Braun C, Zorzi GK, Coelho D, Wajner M, Vargas CR, Dutra-Filho CS (2006) A chemically induced acute model of maple syrup urine disease in rats for neurochemical studies. J Neurosci Methods 155:224–230. https://doi.org/10.1016/j.jneumeth.2006.01.005
Chuang DT, Shih VE (2001) Maple syrup urine disease (branchedchain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 1971–2005
Collins A, Dusinská M, Franklin M, Somorovská M, Petrovská H, Duthie S, Fillion L, Panayiotidis M, Raslová K, Vaughan N (1997) Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ Mol Mutagen 30:139–146. https://doi.org/10.1002/(SICI)1098-2280(1997)30:2%3c139::AID-EM6%3e3.0.CO;2-I
Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407–21. https://doi.org/10.1016/0076-6879(90)86134-h
Evelson P, Travacio M, Repetto M, Escobar J, Llesuy S, Lissi EA (2001) Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys 388:261–266. https://doi.org/10.1006/abbi.2001.2292
Fontella FU, Gassen E, Pulrolnik V, Wannmacher CMD, Klein AB, Wajner M, Dutra CS (2002) Stimulation of lipid peroxidation in vitro in rat brain by metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17:47–54
Giusti P, Lipartiti M, Franceschini D, Schiavo N, Floreani M, Manev H (1996) Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J 10:891–896. https://doi.org/10.1096/fasebj.10.8.8666166
Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634–1658. https://doi.org/10.1111/j.1471-4159.2006.03907.x
Harris RA, Joshi M, Jeoung NH (2004) Mechanisms responsible for regulation of branched-chain amino acid catabolism. Biochem Biophys Res Commun 313:391–396. https://doi.org/10.1016/j.bbrc.2003.11.007
Hoppe JB, Frozza RL, Horn AP, Comiran RA, Bernardi A, Campos MM, Battastini AMO, Salbego C (2010) Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation. J Pineal Res 48:230–238. https://doi.org/10.1111/j.1600-079X.2010.00747.x
Kaur C, Ling E (2008) Antioxidants and Neuroprotection in the Adult and Developing Central Nervous System. Curr Med Chem 15:3068. https://doi.org/10.2174/092986708786848640
Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S, Tan DX (2009) Melatonin: an established antioxidant worthy of use in clinical trials. Molecular medicine 15:43–50. https://doi.org/10.2119/molmed.2008.00117
Kurutas EB (2016) The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J 15:71. https://doi.org/10.1186/s12937-016-0186-5
LeBel CP, Ischiropoulos H, Bondy SC (1992) Evaluation of the probe 2’,7’-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5:227–231. https://doi.org/10.1021/tx00026a012
Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L (2017) Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid Med Cell Longev. https://doi.org/10.1155/2017/2525967
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–75
Malhotra S, Sawhney G, Pandhi P (2004) The therapeutic potential of melatonin: a review of the science. Medsc Gen Med 6:46
Manchester LC, Coto-Montes A, Boga JA, Andersen LP, Zhou Z, Galano A, Vriend J, Tan DX, Reiter RJ (2015) Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res 59:403–419. https://doi.org/10.1111/jpi.12267
Meister A (1965) Biochemistry of the amino acids, 2a edn. Academic Press, New York
Meng X, Li Y, Li S, Zhou Y, Gan RY, Xu DP, Li HB (2017) Dietary Sources and Bioactivities of Melatonin. Nutrients 9:367. https://doi.org/10.3390/nu9040367
Mescka C, Moraes T, Rosa A, Mazzola P, Piccoli B, Jacques C, Dalazen G, Coelho J, Cortes M, Terra M, Regla Vargas C, Dutra-Filho CS (2011) In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease. Metab Brain Dis 26:21–28. https://doi.org/10.1007/s11011-011-9238-x
Mescka CP, Wayhs CA, Vanzin CS, Biancini GB, Guerreiro G, Manfredini V, Souza C, Wajner M, Dutra-Filho CS, Vargas CR (2013) Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect. Int J Dev Neurosci 31:21–24. https://doi.org/10.1016/j.ijdevneu.2012.10.109
Mescka CP, Rosa AP, Schirmbeck G, da Rosa TH, Catarino F, de Souza LO, Guerreiro G, Sitta A, Vargas CR, Dutra-Filho CS (2016) L-carnitine prevents oxidative stress in the brains of rats subjected to a chemically induced chronic model of MSUD. Mol Neurobiol 53:6007–6017. https://doi.org/10.1007/s12035-015-9500-z
Muhammad T, Ali T, Ikram M, Khan A, Alam SI, Kim MO (2018) Melatonin rescue oxidative stress-mediated neuroinflammation/ neurodegeneration and memory impairment in scopolamine-induced amnesia mice model. J Neuroimmune Pharmacol 14:278–294. https://doi.org/10.1007/s11481-018-9824-3
Reiter RJ, Tan DX, Osuna C, Gitto E (2000) Actions of melatonin in the reduction of oxidative stress. J Biomed Sci 7:444–458. https://doi.org/10.1007/bf02253360
Reiter RJ, Tan D, Manchester LC, Qi W (2001) Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. Cell Biochem Biophys 34:237. https://doi.org/10.1385/CBB:34:2:237
Reiter RJ, Tan DX, Fuentes-Broto L (2010) Melatonin: a multitasking molecule. Prog Brain Res 181:127–51. https://doi.org/10.1016/S0079-6123(08)81008-4
Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L (2016) Melatonin as an antioxidant: under promises but over delivers. J Pineal Res 61:253–278. https://doi.org/10.1111/jpi.12360
Ribas GS, Manfredini V, De Mari JF, Wayhs CY, Vanzin CS, Biancini GB, Sitta A, Deon M, Wajner M, Vargas CR (2010) Reduction of lipid and protein damage in patients with disorders of propionate metabolism under treatment: a possible protective role of l-carnitine supplementation. Int J Dev Neurosci 28:127–132. https://doi.org/10.1016/j.ijdevneu.2010.01.002
Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, Reiter RJ (2004) Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36:1–9. https://doi.org/10.1046/j.1600-079X.2003.00092.x
Sarumathi A, Saravanan N (2012) Antioxidant status in kidney and liver of rats during immobilization stress and treated with centell. Int J Biol Sci 2:165–169
Scaini G, Jeremias IC, Morais MO, Borges GD, Munhoz BP, Leffa DD, Andrade VM, Schuck PF, Ferreira GC, Streck EL (2012) DNA damage in an animal model of maple syrup urine disease. Mol Genet Metab 106:169–174. https://doi.org/10.1016/j.ymgme.2012.04.009
Scaini G, Jeremias GC, Furlanetto CB, Dominguini D, Comim CM, Quevedo J, Schuck PF, Ferreira GC, Streck EL (2013) Behavioral responses in rats submitted to chronic administration of branched-chain amino acids. JIMD reports 13:159–167. https://doi.org/10.1007/8904_2013_274
Scaini G, Morais MO, Galant LS, Vuolo F, Dall’Igna DM, Pasquali MA, Ramos VM, Gelain DP, Moreira JC, Schuck PF, Ferreira GC, Soriano FG, Dal-Pizzol F, Streck EL (2014) Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown. Mol Neurobiol 50: 358–367. https://doi.org/10.1007/s12035-013-8618-0
Schaefer M, Hardeland R (2009) The melatonin metabolite N1-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger. J Pineal Res 46:49–52. https://doi.org/10.1111/j.1600-079X.2008.00614.x
Sitta A, Barschak AG, Deon M, Mari J, Barden AT, Vanzin CS, Biancini GB, Schwartz LV, Wajner M, Vargas CR (2009) l-Carnitine blood levels and oxidative stress in treated phenylketonuric patients. Cell Mol Neurobiol 29: 211–218. https://doi.org/10.1007/s10571-008-9313-y
Tan DX, Manchester LC, Esteban-Zubero E, Zhou Z, Reiter RJ (2015) Melatonin as a potent and inducible endogenous antioxidant: synthesis and metabolism. Molecules 20:18886–18906. https://doi.org/10.3390/molecules201018886
Taschetto L, Scaini G, Zapelini HG, Ramos ÂC, Strapazzon G, Andrade VM, Réus GZ, Michels M, Dal-Pizzol F, Quevedo J, Schuck PF, Ferreira GC, Streck EL (2017) Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors. Metabolic Brain Disease 32:1507–1518. https://doi.org/10.1007/s11011-017-0035-z
Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206–21. https://doi.org/10.1002/(sici)1098-2280(2000)35:3%3c206::aid-em8%3e3.0.co;2-j
Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N, Fougerou C (2017) Melatonin: pharmacology, functions and therapeutic benefits. Curr Neuropharmacol 15:434–443. https://doi.org/10.2174/1570159X14666161228122115
Treacy E, Clow CL, Reade TR, Chitayat D, Mamer OA, Scriver CR (1992) Maple syrup urine disease: interrelationship between branchedchain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination. J Inherit Metab Dis 15:121–135
Uttara B, Singh AV, Zamboni P, Mahajan RT (2009) Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7:65–74. https://doi.org/10.2174/157015909787602823
Wajner M, Latini A, Wyse AT, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27:427–448. https://doi.org/10.1023/B:BOLI.0000037353.13085.e2
Wen J, Ariyannur PS, Ribeiro R, Tanaka M, Moffett JR, Kirmani BF, Namboodiri AMA, Zhang Y (2016) Efficacy of N-Acetylserotonin and melatonin in the EAE model of multiple sclerosis. J Neuroimmune Pharmacol 11:763–773. https://doi.org/10.1007/s11481-016-9702-9
Wessler LB, Ramos VD, Pasquali MA, Moreira JC, Streck EL (2019a) Administration of branched-chain amino acids increases the susceptibility to lipopolysaccharide-induced inflammation in young Wistar rats. Int J Dev Neurosci 78:210–214. https://doi.org/10.1016/j.ijdevneu.2019a.07.007
Wessler LB, Farias HR, Ronsani JF, Candiotto G, Dos Santos PCL, de Oliveira J, Rico EP, Streck EL (2019b) Acute exposure to leucine modifies behavioral parameters and cholinergic activity in zebrafish. Int J Dev Neurosci 78:222–226. https://doi.org/10.1016/j.ijdevneu.2019b.10.001
Wu H, Shao A, Zhao M, Chen S, Yu J, Zhou J, Liang F, Shi L, Dixon BJ, Wang Z, Ling C, Hong Y, Zhang J (2016) Melatonin attenuates neuronal apoptosis through up-regulation of K+–Cl – cotransporter KCC2 expression following traumatic brain injury in rats. J Pineal Res 61:241–250. https://doi.org/10.1111/jpi.12344
Yagi K (1998) Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol 108:107–110. https://doi.org/10.1385/0-89603-472-0:107
Acknowledgements
This research was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (FAPESC) and Universidade do Extremo Sul Catarinense (UNESC).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have reviewed the contents of the manuscript, have an approved of its contents and validated the accuracy of the data and they have no financial or personal conflicts of interest related to this work.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wessler, L.B., Ise, K., Lemos, I.C. et al. Melatonin ameliorates oxidative stress and DNA damage of rats subjected to a chemically induced chronic model of Maple Syrup Urine Disease. Metab Brain Dis 35, 905–914 (2020). https://doi.org/10.1007/s11011-020-00572-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-020-00572-9